102 related articles for article (PubMed ID: 8614366)
21. Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors.
Hunold A; Weddeling N; Paulussen M; Ranft A; Liebscher C; Jürgens H
Pediatr Blood Cancer; 2006 Nov; 47(6):795-800. PubMed ID: 16411206
[TBL] [Abstract][Full Text] [Related]
22. Proceedings: Recent progress in the chemotherapy of primary tumors of bone.
Gottlieb JA; Fernandez CH
Proc Natl Cancer Conf; 1972; 7():959-62. PubMed ID: 4587669
[No Abstract] [Full Text] [Related]
23. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
24. [Chemotherapy of osteo and Ewing sarcomas].
Höffken K; Seeber S; Schmidt CG; Hupfauer W
Z Orthop Ihre Grenzgeb; 1978 Aug; 116(4):534-7. PubMed ID: 309223
[No Abstract] [Full Text] [Related]
25. How to treat the Ewing's family of sarcomas in adult patients.
Scurr M; Judson I
Oncologist; 2006 Jan; 11(1):65-72. PubMed ID: 16401715
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
Bacci G; Longhi A; Ferrari S; Mercuri M; Versari M; Bertoni F
Acta Oncol; 2006; 45(4):469-75. PubMed ID: 16760184
[TBL] [Abstract][Full Text] [Related]
27. [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors.
Hawkins DS; Schuetze SM; Butrynski JE; Rajendran JG; Vernon CB; Conrad EU; Eary JF
J Clin Oncol; 2005 Dec; 23(34):8828-34. PubMed ID: 16314643
[TBL] [Abstract][Full Text] [Related]
28. Ewing's sarcoma of the foot.
Adkins CD; Kitaoka HB; Seidl RK; Pritchard DJ
Clin Orthop Relat Res; 1997 Oct; (343):173-82. PubMed ID: 9345223
[TBL] [Abstract][Full Text] [Related]
29. Osteosarcoma and Ewing's sarcoma in children and adolescents: retrospective clinicopathological study.
Ilić I; Manojlović S; Cepulić M; Orlić D; Seiwerth S
Croat Med J; 2004 Dec; 45(6):740-5. PubMed ID: 15578809
[TBL] [Abstract][Full Text] [Related]
30. [Surgery versus radiotherapy in Ewing's sarcoma with good prognosis. Analysis of the CESS-86 data].
Dunst J; Hoffmann C; Ahrens S; Jürgens H
Strahlenther Onkol; 1996 May; 172(5):244-8; discussion 249. PubMed ID: 8633255
[TBL] [Abstract][Full Text] [Related]
31. Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide.
Sancéau J; Poupon MF; Delattre O; Sastre-Garau X; Wietzerbin J
Oncogene; 2002 Oct; 21(50):7700-9. PubMed ID: 12400012
[TBL] [Abstract][Full Text] [Related]
32. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
[TBL] [Abstract][Full Text] [Related]
33. Primitive neuroectodermal tumor and extraskeletal Ewing sarcoma arising primarily around the spinal column: report of four cases and a review of the literature.
Harimaya K; Oda Y; Matsuda S; Tanaka K; Chuman H; Iwamoto Y
Spine (Phila Pa 1976); 2003 Oct; 28(19):E408-12. PubMed ID: 14520055
[TBL] [Abstract][Full Text] [Related]
34. Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcoma.
Furth C; Amthauer H; Denecke T; Ruf J; Henze G; Gutberlet M
Pediatr Blood Cancer; 2006 Oct; 47(5):607-11. PubMed ID: 16261559
[TBL] [Abstract][Full Text] [Related]
35. [Adjuvant cytostatic chemotherapy in osteo and Ewing sarcoma].
Kotz R; Plattner E
Haematol Blood Transfus; 1978; 22():127-36. PubMed ID: 285912
[No Abstract] [Full Text] [Related]
36. Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of sequential color Doppler sonography in predicting histopathologic response.
van der Woude HJ; Bloem JL; van Oostayen JA; Nooy MA; Taminiau AH; Hermans J; Reynierse M; Hogendoorn PC
AJR Am J Roentgenol; 1995 Jul; 165(1):125-33. PubMed ID: 7785571
[TBL] [Abstract][Full Text] [Related]
37. [Place of the pathologist in the management of primary bone tumors (osteosarcoma and Ewing's family tumors after neoadjuvant treatment)].
Gomez-Brouchet A; Bouvier C; Decouvelaere AV; Larousserie F; Aubert S; Leroy X; Guinebretière JM; Coulomb A; Cassagnau E; de Muret A; Audard V; Marie B; de Pinieux G
Ann Pathol; 2011 Dec; 31(6):455-65. PubMed ID: 22172118
[TBL] [Abstract][Full Text] [Related]
38. [Changes in the T- and B-lymphocyte ratio in bone sarcoma patients before and after carminomycin treatment].
Vatin AE; Bizer VA
Antibiotiki; 1980 Nov; 25(11):864-7. PubMed ID: 6969572
[TBL] [Abstract][Full Text] [Related]
39. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.
Holscher HC; Bloem JL; Nooy MA; Taminiau AH; Eulderink F; Hermans J
AJR Am J Roentgenol; 1990 Apr; 154(4):763-9. PubMed ID: 2107673
[TBL] [Abstract][Full Text] [Related]
40. [Effects of certain chemopreparations on transplantable strains of human tumors, melanoma and Ewing sarcoma, obtained from tissue cultures].
Revazova ES
Vestn Akad Med Nauk SSSR; 1980; (12):81-4. PubMed ID: 7257580
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
